Yukihiko Fujii

Yukihiko Fujii

Auto-generated profile, based on publicly available information

Yukihiko Fujii

Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1998 in Stroke
Verified
Journal Article
Open access
PDF file
YFYukihiko Fujii
Yukihiko Fujii
STShigekazu Takeuchi
Shigekazu Takeuchi
OSOsamu Sasaki
Osamu Sasaki
TMTakashi Minakawa
Takashi Minakawa
RTRyuichi Tanaka
Ryuichi Tanaka
Background and Purpose —We conducted this study to determine, through use of multivariate analyses, the independent predictors of hematoma enlargement occurring after hospital admission in patients with spontaneous intracerebral hemorrhage (ICH). Methods —We reviewed 627 patients with ICH admitted within 24 hours of onset. The first CT was performed at admission and the second within 24 hours of admission, and a blood sample was taken for laboratory examinations. Univariate and multivariate analyses were performed to assess the relationships between hematoma enlargement and time from onset, consciousness level, CT findings, amount of alcohol consumption, systolic blood pressure at and after admission, clinical outcome, and hematologic parameters. Results —Eighty-eight patients (14.0%) showed enlarged hematomas after admission. Multivariate analyses revealed that the following five factors were independently associated with hematoma enlargement: the time from onset (odds ratio [OR], 0.26 for a 1-SD change; 4.9 hours; P <0.001); the amount of alcohol consumption (OR, 1.50 for 1 SD; 46.3 g/d; P =0.002); the sharp of hematoma (OR, 1.40 for 1 SD; 0.45 round; P =0.006); the presence of consciousness disturbance (OR, 1.38 for 1 SD; 0.50 coma; P =0.026); and the level of fibrinogen (OR, 0.74 for 1 SD; 87.1 mg/dL; P =0.042). Hematoma enlargement was an independent factor increasing the mortality rate in the ICH patients (OR, 1.57; P <0.001). Conclusions —A particularly high likelihood of hematoma enlargement was observed in patients who (in order of importance) were admitted shortly after onset, who were heavy drinkers; who had an irregularly shaped hematoma, whose consciousness was disturbed, and who had a low level of fibrinogen.

7 November 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
MNManabu Natsumeda
Manabu Natsumeda
HIHironaka Igarashi
Hironaka Igarashi
TNToshiharu Nomura
Toshiharu Nomura
OROgura Ryosuke
Ogura Ryosuke
YTYoshihiro Tsukamoto
Yoshihiro Tsukamoto
YFYukihiko Fujii
Yukihiko Fujii
Previous magnetic resonance spectroscopy (MRS) and mass spectroscopy studies have shown accumulation of 2-hydroxyglutarate (2HG) in mutant isocitrate dehydrogenase (IDH) gliomas. IDH mutation is known to be a powerful positive prognostic marker in malignant gliomas. Hence, 2HG accumulation in gliomas was assumed to be a positive prognostic factor in gliomas, but this has not yet been proven. Here, we analyzed 52 patients harboring World Health Organization (WHO) grade II and III gliomas utilizing 3.0-tesla MRS. Mutant IDH gliomas showed significantly higher accumulation of 2HG (median 5.077 vs. 0.000, p =0.0002, Mann-Whitney test). 2HG was detectable in all mutant IDH gliomas, whereas in 10 out of 27 (37.0%) wild-type IDH gliomas, 2HG was below the detectable range (2HG =0) (p =0.0003, chi-squared test). Screening for IDH mutation by 2HG analysis was highly sensitive (cutoff 2HG =1.489 mM, sensitivity 100.0%, specificity 72.2%). Gliomas with high 2HG accumulation had better overall survival than gliomas with low 2HG accumulation (p =0.0401, Kaplan-Meier analysis). 2HG accumulation detected by 3.0-tesla MRS not only correlates well with IDH status, but also positively correlates with survival in WHO grade II and III gliomas.

1 April 2001 in Stroke
Verified
Journal Article
Open access
PDF file
YFYukihiko Fujii
Yukihiko Fujii
STShigekazu Takeuchi
Shigekazu Takeuchi
AHAtsuko Harada
Atsuko Harada
HAHiroshi Abe
Hiroshi Abe
OSOsamu Sasaki
Osamu Sasaki
RTRyuichi Tanaka
Ryuichi Tanaka
Background and Purpose —There is no in-depth information available on the changes in hemostatic systems in patients in the acute phase of spontaneous intracerebral hemorrhage (ICH). This study was conducted to assess the relationships between the changes in hemostatic systems and clinical parameters in patients in acute-phase ICH. Methods —The records of 358 patients admitted within 6 hours of onset of ICH were reviewed to examine the relationships between changes in hemostatic systems and computed tomographic findings and clinical parameters. Results —The white blood cell counts and the levels of thrombin-antithrombin complex, plasmin-antiplasmin complex, and D-dimer in patients with intraventricular extension (IVE) or subarachnoid hemorrhage (SAH) were significantly ( P <0.05) higher than those in patients without IVE or SAH. Most of the hemostatic system parameters in patients without IVE or SAH showed no significant differences compared with normal subjects. Multiple linear regression analysis revealed that the levels of thrombin-antithrombin complex significantly increased with an increase in the amount of SAH ( P <0.001) and IVE ( P <0.001). The levels of thrombin-antithrombin complex were not significantly associated with the volume of intraparenchymal hematoma. The level of the complex, however, was significantly ( P <0.001) and independently associated with the presence of IVE or SAH (multiple logistic regression analysis). Conclusions —The systemic activation of hemostatic systems in ICH patients seems to take place only when blood reaches the subarachnoid space. The intraparenchymal hematoma itself seems unlikely to activate hemostatic systems in peripheral blood, although the hematoma is expected to cause local activation of hemostatic systems.

1 January 2008 in Journal of Neurosurgery
Verified
Journal Article
Closed access
YYYuichiro Yoneoka
Yuichiro Yoneoka
NWNaoto Watanabe
Naoto Watanabe
HMHitoshi Matsuzawa
Hitoshi Matsuzawa
ITItaru Tsumanuma
Itaru Tsumanuma
SUSatoshi Ueki
Satoshi Ueki
YFYukihiko Fujii
Yukihiko Fujii
Object: Three-dimensional anisotropy contrast (3DAC) magnetic resonance (MR) imaging provides clear depiction of neuronal fibers. The aim of this study was to identify intracavernous cranial nerves in patients with pituitary macro-adenoma and in healthy volunteers by using 3DAC MR imaging on a 3-tesla system and to preoperatively predict cavernous sinus invasion by pituitary macroadenoma. Methods: Thirty-three patients (cavernous sinuses in 66 sides) with pituitary macroadenomas and 25 healthy volunteers (50 sides) participated in this study. Coronal 3DAC MR images constructed from diffusion weighted images, acquired with periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) sequences, and T2-weighted reverse images were obtained at the same anatomical locations using a 3-tesla MR imaging system. Attempts were made to identify the cranial nerves. Results: The oculomotor and ophthalmic/maxillary nerves were preoperatively identified in all sides (66 sides in patients and 50 sides in healthy volunteers) on 3DAC MR images. In the 33 patients, cavernous sinus invasion was revealed in 10 (12 [18.2%] of 66 sides) by intraoperative endoscopic observation. Coronal 3DAC MR images revealed that the oculomotor nerves were half surrounded with adenoma in all 12 of these sides, and the ophthalmic/maxillary nerves were half encapsulated with tumor (sensitivity/specificity: 100%/100% and 83%/100%, respectively). Conclusions: Preoperative evaluation of pituitary macroadenomas using 3DAC PROPELLER MR imaging on a 3-tesla system is likely to be a powerful noninvasive method of detecting cavernous sinus invasion, which can potentially dominate the therapeutic strategy for these lesions.

12 November 2012 in Neurological Research
Verified
Journal Article
Closed access
TSTakatoshi Sorimachi
Takatoshi Sorimachi
YIYasushi Ito
Yasushi Ito
KMKenichi Morita
Kenichi Morita
YJYasushi Jimbo
Yasushi Jimbo
KNKazuhiko Nishino
Kazuhiko Nishino
YFYukihiko Fujii
Yukihiko Fujii
Objectives: The selection of therapeutic modalities, including endovascular coil embolization and surgical clipping, for management of unruptured paraclinoid aneurysms, remains controversial. Detailed long-term outcome data for endovascular coil embolization of unruptured paraclinoid aneurysms are still lacking. Thus, we evaluated the safety and efficacy of coil embolization of unruptured paraclinoid aneurysms. Methods: From January 1998 to July 2010, 138 patients underwent endovascular coiling for 140 unruptured paraclinoid aneurysms. Their medical records and radiologic images were reviewed retrospectively. Results: Complications occurred in 5·7% of 140 procedures and the morbidity rate was 0·7%. Of the 140 unruptured paraclinoid aneurysms, a total of 111 aneurysms underwent follow-up imaging evaluation at 2 years or more, or showing reopening on imaging studies within 2 years (65·6±37·2 months). Multivariate analysis revealed two predictors for reopening of the aneurysms: a maximum diameter of aneurysms and a dome/neck ratio of aneurysms (P<0·05). Reopening rates of aneurysms with maximum sizes of 10 mm were 1%, 25%, and 75%, respectively. Reopening rates were significantly different among the three groups (P<0·05). In aneurysms with a maximum diameter of 8–10 mm, there was a significant difference of dome/neck ratios between the presence and absence of reopened aneurysms (P<0·05). Discussion: The results indicate that endovascular coil embolization is a safe and effective treatment modality in selected patients with unruptured paraclinoid aneurysms. Consideration of the aneurysm size and the dome/neck ratio could assist in the selection of therapeutic modalities for these aneurysms.

1 April 2018 in World Neurosurgery
Verified
Journal Article
Closed access
PDF file
MNManabu Natsumeda
Manabu Natsumeda
TUTakeo Uzuka
Takeo Uzuka
JWJun Watanabe
Jun Watanabe
MFMasafumi Fukuda
Masafumi Fukuda
YAYasuhisa Akaiwa
Yasuhisa Akaiwa
YFYukihiko Fujii
Yukihiko Fujii